UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 409

Sortiert nach

Clinical development of metabolic inhibitors for oncology

The Journal of clinical investigation, 2022-01, Vol.132 (1), p.1-15

2022

Volltextzugriff (PDF)

Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid Network

Journal of medicinal chemistry, 2021-01, Vol.64 (1), p.279-297

2021

Volltextzugriff (PDF)

We're Not "DON" Yet: Optimal Dosing and Prodrug Delivery of 6-Diazo-5-oxo-L-norleucine

Molecular cancer therapeutics, 2018-09, Vol.17 (9), p.1824-1832

2018

Volltextzugriff (PDF)

Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion

Science (American Association for the Advancement of Science), 2019-11, Vol.366 (6468), p.1013-1021

2019

Volltextzugriff (PDF)

Pharmacological mechanisms of 5-HT3 and tachykinin NK1 receptor antagonism to prevent chemotherapy-induced nausea and vomiting

European journal of pharmacology, 2012-06, Vol.684 (1-3), p.1-7

2012

Volltextzugriff (PDF)

Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis

eLife, 2014-05, Vol.3, p.e02523

2014

Volltextzugriff (PDF)

Preventing Allograft Rejection by Targeting Immune Metabolism

Cell reports (Cambridge), 2015-10, Vol.13 (4), p.760-770

2015

Volltextzugriff (PDF)

Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells

Cell metabolism, 2012-01, Vol.15 (1), p.110-121

2012

Volltextzugriff (PDF)

Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties

PloS one, 2015-05, Vol.10 (5), p.e0124481-e0124481

2015

Volltextzugriff (PDF)

HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment

Nature reviews. Neurology, 2016-04, Vol.12 (4), p.234

2016

Volltextzugriff (PDF)

Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells

The Journal of clinical investigation, 2020-07, Vol.130 (7), p.3865-3884

2020

Volltextzugriff (PDF)

Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis

The Journal of clinical investigation, 2015-06, Vol.125 (6), p.2293-2306

2015

Volltextzugriff (PDF)

Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer

Proceedings of the National Academy of Sciences - PNAS, 2016-09, Vol.113 (36), p.E5328-E5336

2016

Volltextzugriff (PDF)

Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects

Frontiers in chemistry, 2022-05, Vol.10, p.889737

2022

Volltextzugriff (PDF)

Neuronal deletion of nSMase2 reduces the production of Aβ and directly protects neurons

Neurobiology of disease, 2023-02, Vol.177, p.105987, Article 105987

2023

Volltextzugriff (PDF)

The pathogenesis of, and pharmacological treatment for, Canavan disease

Drug discovery today, 2022-09, Vol.27 (9), p.2467-2483

2022

Volltextzugriff (PDF)

Targeting Mitochondria in Tumor-Associated Macrophages using a Dendrimer-Conjugated TSPO Ligand that Stimulates Antitumor Signaling in Glioblastoma

Biomacromolecules, 2020-09, Vol.21 (9), p.3909-3922

2020

Volltextzugriff (PDF)

Mechanisms and latest clinical studies of new NK1 receptor antagonists for chemotherapy-induced nausea and vomiting: Rolapitant and NEPA (netupitant/palonosetron)

Cancer treatment reviews, 2015-12, Vol.41 (10), p.904-913

2015

Volltextzugriff (PDF)

Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HIV-associated neurocognitive disorders in EcoHIV-infected mice

AIDS (London), 2019-05, Vol.33 (6), p.973-984

2019

Volltextzugriff (PDF)

Maternal inflammation leads to impaired glutamate homeostasis and up-regulation of glutamate carboxypeptidase II in activated microglia in the fetal/newborn rabbit brain

Neurobiology of disease, 2016-10, Vol.94, p.116-128

2016

Volltextzugriff (PDF)

Empirical Analysis of Drug Targets for Nervous System Disorders

ACS chemical neuroscience, 2024-02, Vol.15 (3), p.394-399

2024

Volltextzugriff (PDF)

Discovery of PSMA in the prostate of the common marmoset (Callithrix jacchus)

The Prostate, 2024-08, Vol.84 (11), p.1086-1088

2024

Volltextzugriff (PDF)

Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1

Cancer research (Chicago, Ill.), 2010-11, Vol.70 (22), p.8981-8987

2010

Volltextzugriff (PDF)

High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells

PloS one, 2015-08, Vol.10 (8), p.e0127785

2015

Volltextzugriff (PDF)

Neuromuscular NMDA Receptors Modulate Developmental Synapse Elimination

The Journal of neuroscience, 2016-08, Vol.36 (34), p.8783-8789

2016

Volltextzugriff (PDF)

1 – 25 von 409

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(397)
Mit Volltextzugriff
(379)

Publikationsform

Sprache

Englisch
(408)
Japanisch
(52)

Erscheinungsjahr

n.n

Thema

Science & Technology
(262)
Life Sciences & Biomedicine
(242)
Animals
(187)
Humans
(127)
Pharmacology & Pharmacy
(107)
Mice
(94)
Male
(93)
Neurosciences
(75)
Neurosciences & Neurology
(74)
Rats
(66)
Chemistry, Medicinal
(56)
Biological And Medical Sciences
(53)
Biochemistry & Molecular Biology
(48)
Medical Sciences
(45)
Glutamate Carboxypeptidase Ii
(43)
Dose-Response Relationship, Drug
(40)
Glutamate Carboxypeptidase Ii - Antagonists & Inhibitors
(40)
Enzyme Inhibitors - Pharmacology
(38)
Female
(37)
Rats, Sprague-Dawley
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Clinical development of metabolic inhibitors for oncology

Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid Network

We're Not "DON" Yet: Optimal Dosing and Prodrug Delivery of 6-Diazo-5-oxo-L-norleucine

Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion

Pharmacological mechanisms of 5-HT3 and tachykinin NK1 receptor antagonism to prevent chemotherapy-induced nausea and vomiting

Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis

Preventing Allograft Rejection by Targeting Immune Metabolism

Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells

Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties

HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment

Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells

Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis

Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer

Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects

Neuronal deletion of nSMase2 reduces the production of Aβ and directly protects neurons

The pathogenesis of, and pharmacological treatment for, Canavan disease

Targeting Mitochondria in Tumor-Associated Macrophages using a Dendrimer-Conjugated TSPO Ligand that Stimulates Antitumor Signaling in Glioblastoma

Mechanisms and latest clinical studies of new NK1 receptor antagonists for chemotherapy-induced nausea and vomiting: Rolapitant and NEPA (netupitant/palonosetron)

Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HIV-associated neurocognitive disorders in EcoHIV-infected mice

Maternal inflammation leads to impaired glutamate homeostasis and up-regulation of glutamate carboxypeptidase II in activated microglia in the fetal/newborn rabbit brain

Empirical Analysis of Drug Targets for Nervous System Disorders

Discovery of PSMA in the prostate of the common marmoset (Callithrix jacchus)

Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1

High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells

Neuromuscular NMDA Receptors Modulate Developmental Synapse Elimination

Suchergebnisse filtern